Israeli-based generics maker Teva is in the process of closing 11 plants in its global network of 70, 15% of the total, and evaluating another 16 to see where else it might find savings.
written on 06.05.2014
Israeli-based generics maker Teva is in the process of closing 11 plants in its global network of 70, 15% of the total, and evaluating another 16 to see where else it might find savings.
See our Cookie Privacy Policy Here